Related Experiment Video
Updated: Jun 14, 2026
06:46
Traumatic Peripheral Nerve Injury in Mice
Published on: March 25, 2022
2.1K
Impaired peripheral nerve regeneration in type-2 diabetic mouse model
Vuong M Pham1, Nguyen Huu Tu1, Tayo Katano1
1Department of Medical Chemistry, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, 573-1010, Japan.
The European Journal of Neuroscience
|November 10, 2017
Summary
Peripheral neuropathy in type-2 diabetes impairs nerve regeneration. Targeting PTEN shows promise for improving axonal transport and functional recovery in diabetic neuropathy models.
Area of Science:
- Neuroscience
- Endocrinology
- Regenerative Medicine
Background:
- Diabetic neuropathy is a common complication of type-2 diabetes, affecting sensory nerve fibers and causing pain.
- Current treatments for diabetic neuropathy are limited, emphasizing glucose control and lifestyle changes.
Purpose of the Study:
- To investigate impaired nerve regeneration in a type-2 diabetes mouse model.
- To explore the potential of PTEN inhibition as a therapeutic strategy for diabetic neuropathy.
Main Methods:
- A type-2 diabetes mouse model was created using streptozotocin and nicotinamide injections.
- Sciatic nerve transection and regeneration were analyzed in diabetic and control mice.
- PTEN expression and the effect of a PTEN inhibitor on nerve regeneration were evaluated.
Main Results:
- Diabetic mice exhibited delayed functional recovery and nerve regeneration post-axotomy.
- Increased PTEN expression was observed in dorsal root ganglion (DRG) neurons of diabetic mice.
- PTEN inhibitor administration promoted axonal transport and functional recovery in diabetic mice.
Conclusions:
- Peripheral nerve regeneration is impaired in type-2 diabetic mice.
- The developed model is suitable for studying diabetic neuropathy pathogenesis and treatment.
- PTEN inhibition represents a potential therapeutic avenue for enhancing nerve repair in diabetic neuropathy.
